User:Mr. Ibrahem/Ozanimod

Ozanimod, sold under the brand name Zeposia, is a medication used to treat multiple sclerosis (MS) and ulcerative colitis (UC). For MS this includes clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease. In UC it is used in those with moderate to severe disease. It is taken by mouth.

Common side effects include upper respiratory infection, liver inflammation, low blood pressure with standing, urinary tract infection, and back pain. Other side effects may include heart arrhythmias, high blood pressure, and macular edema. Use during or in the 3 months before pregnancy may harm the baby. It is a sphingosine-1-phosphate (S1P) receptor agonist, which results in stopping lymphocytes from going to the brain and spinal cord.

Ozanimod was approved for medical use in the United States, Europe, and Australia in 2020. In the United Kingdom 4 weeks of medication costs the NHS about £1,400 as of 2021. In the United States this amount costs about 7,200 USD.